European best practice quo vadis? From European Best Practice Guidelines (EBPG) to European Renal Best Practice (ERBP).
暂无分享,去创建一个
C. Wanner | W. van Biesen | F. Locatelli | C. Zoccali | D. Abramowicz | G. Spasovski | R. Vanholder | K. Eckardt | A. Covic | D. Fouque | J. Tattersall | E. Lindley | J. Cannata-Andía | P. Cochat | O. Heimburger | Alison McLeod
[1] C. Ronco,et al. Guidelines Have Done More Harm than Good , 2008, Blood Purification.
[2] F. Locatelli,et al. Clinical policies on the management of chronic kidney disease patients in Italy. , 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[3] J. Himmelfarb. Chronic kidney disease and the public health: gaps in evidence from interventional trials. , 2007, JAMA.
[4] G. Eknoyan,et al. The Kidney Disease: improving Global Outcomes website: comparison of guidelines as a tool for harmonization. , 2007, Kidney international.
[5] Raymond Vanholder,et al. EBPG guideline on nutrition. , 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[6] Raymond Vanholder,et al. EBPG guideline on haemodynamic instability. , 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[7] C. Wanner,et al. EBPG guideline on dialysis strategies. , 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[8] C. Wanner,et al. EBPG on Vascular Access. , 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[9] G. Eknoyan,et al. Grading evidence and recommendations for clinical practice guidelines in nephrology. A position statement from Kidney Disease: Improving Global Outcomes (KDIGO). , 2006, Kidney international.
[10] D. Coyne. Influence of industry on renal guideline development. , 2006, Clinical journal of the American Society of Nephrology : CJASN.
[11] A. Garg,et al. Underrepresentation of renal disease in randomized controlled trials of cardiovascular disease. , 2006, JAMA.
[12] G. Eknoyan,et al. Improving outcomes for dialysis patients in the international Dialysis Outcomes and Practice Patterns Study. , 2006, Clinical journal of the American Society of Nephrology : CJASN.
[13] G. Eknoyan,et al. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). , 2005, Kidney international.
[14] K. D. Workgroup. K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients. , 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[15] Jonathan C Craig,et al. The number, quality, and coverage of randomized controlled trials in nephrology. , 2004, Journal of the American Society of Nephrology : JASN.
[16] W. Owen,et al. Patterns of care for patients with chronic kidney disease in the United States: dying for improvement. , 2003, Journal of the American Society of Nephrology : JASN.
[17] A. Nissenson,et al. Opportunities for improving the care of patients with chronic renal insufficiency: current practice patterns. , 2001, Journal of the American Society of Nephrology : JASN.
[18] Alessandro Liberati,et al. Practice guidelines developed by specialty societies: the need for a critical appraisal , 2000, The Lancet.
[19] J. Grimshaw,et al. Potential benefits, limitations, and harms of clinical guidelines , 1999, BMJ.
[20] L. Wilkins. Guidelines for the treatment of mild hypertension: memorandum from a WHO/ISH meeting. , 1983, Bulletin of the World Health Organization.